Nutra Pharma Announces Plans for Registration in South Africa

Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that they have begun the process of registering their homeopathic treatment for chronic pain, Nyloxina , in the country of South Africa.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130822005694&newsLang=en&ndmConfigId=1000639&vnsId=41